GHRL and cancer: In this context, obestatin, a 23-amino acid peptide derived from the ghrelin peptide precursor (preproghrelin), was originally identified in the stomach [3], and its receptor, GPR39, was demonstrated to exert a pivotal role in many physiological functions and in multiple diseases, including cancer.